Who are Minoxidil Tablets's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Rogaine, Minoxidil 5% Topical Solution, Minoxidil lotion 2%, Minoxidil lotion 1%, KLH-2109, Minoxidil Topical.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/minoxidil-tablets.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-14 · How we verify

Minoxidil Tablets — Competitive Intelligence Brief

Minoxidil Tablets (Minoxidil Tablets) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Potassium channel opener; topical/systemic antialopecia agent. Area: Dermatology.

phase 3 Potassium channel opener; topical/systemic antialopecia agent ATP-sensitive potassium channels (KATP); hair follicle growth pathways Dermatology Small molecule Live · refreshed every 30 min

Target snapshot

Minoxidil Tablets (Minoxidil Tablets) — Industrial Farmacéutica Cantabria, S.A.. Minoxidil is a potassium channel opener that vasodilates blood vessels and may stimulate hair follicle growth through increased blood flow and prolongation of the anagen (growth) phase.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Minoxidil Tablets TARGET	Minoxidil Tablets	Industrial Farmacéutica Cantabria, S.A.	phase 3	Potassium channel opener; topical/systemic antialopecia agent	ATP-sensitive potassium channels (KATP); hair follicle growth pathways
Rogaine	minoxidil	Generic (originally Upjohn/Pfizer)	marketed	Vasodilator (potassium channel opener), Hair growth stimulant	ATP-sensitive inward rectifier potassium channel 1, Sulfonylurea receptor 2, Kir6.2	1988-08-18
Minoxidil 5% Topical Solution	Minoxidil 5% Topical Solution	Triple Hair Inc	marketed	Potassium channel opener	ATP-sensitive potassium channels (KATP)
Minoxidil lotion 2%	Minoxidil lotion 2%	Mae Fah Luang University Hospital	marketed	Potassium channel opener / topical hair growth stimulant	ATP-sensitive potassium channels (KATP); exact follicle-specific target unclear
Minoxidil lotion 1%	Minoxidil lotion 1%	Mae Fah Luang University Hospital	marketed	Potassium channel opener / topical hair growth stimulant	ATP-sensitive potassium channels
KLH-2109	KLH-2109	Kissei Pharmaceutical Co., Ltd.	marketed	Potassium channel opener	ATP-sensitive potassium channel
Minoxidil Topical	Minoxidil Topical	Dr. dr. Lili Legiawati, SpKK(K)	marketed	Potassium channel opener	ATP-sensitive potassium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Potassium channel opener; topical/systemic antialopecia agent class)

Industrial Farmacéutica Cantabria, S.A. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Minoxidil Tablets — Competitive Intelligence Brief. https://druglandscape.com/ci/minoxidil-tablets. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab